1. Home
  2. IKNA vs BOTJ Comparison

IKNA vs BOTJ Comparison

Compare IKNA & BOTJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IKNA
  • BOTJ
  • Stock Information
  • Founded
  • IKNA 2016
  • BOTJ 1998
  • Country
  • IKNA United States
  • BOTJ United States
  • Employees
  • IKNA N/A
  • BOTJ N/A
  • Industry
  • IKNA Biotechnology: Pharmaceutical Preparations
  • BOTJ Major Banks
  • Sector
  • IKNA Health Care
  • BOTJ Finance
  • Exchange
  • IKNA Nasdaq
  • BOTJ Nasdaq
  • Market Cap
  • IKNA 61.8M
  • BOTJ 59.7M
  • IPO Year
  • IKNA 2021
  • BOTJ N/A
  • Fundamental
  • Price
  • IKNA $1.11
  • BOTJ $13.90
  • Analyst Decision
  • IKNA Buy
  • BOTJ
  • Analyst Count
  • IKNA 2
  • BOTJ 0
  • Target Price
  • IKNA $3.00
  • BOTJ N/A
  • AVG Volume (30 Days)
  • IKNA 84.2K
  • BOTJ 7.2K
  • Earning Date
  • IKNA 05-12-2025
  • BOTJ 04-29-2025
  • Dividend Yield
  • IKNA N/A
  • BOTJ 2.88%
  • EPS Growth
  • IKNA N/A
  • BOTJ N/A
  • EPS
  • IKNA N/A
  • BOTJ 1.75
  • Revenue
  • IKNA N/A
  • BOTJ $45,028,000.00
  • Revenue This Year
  • IKNA N/A
  • BOTJ N/A
  • Revenue Next Year
  • IKNA N/A
  • BOTJ N/A
  • P/E Ratio
  • IKNA N/A
  • BOTJ $7.95
  • Revenue Growth
  • IKNA N/A
  • BOTJ 5.24
  • 52 Week Low
  • IKNA $0.97
  • BOTJ $9.65
  • 52 Week High
  • IKNA $1.94
  • BOTJ $17.05
  • Technical
  • Relative Strength Index (RSI)
  • IKNA 38.47
  • BOTJ 48.64
  • Support Level
  • IKNA $1.06
  • BOTJ $13.30
  • Resistance Level
  • IKNA $1.25
  • BOTJ $14.74
  • Average True Range (ATR)
  • IKNA 0.10
  • BOTJ 0.61
  • MACD
  • IKNA 0.00
  • BOTJ -0.10
  • Stochastic Oscillator
  • IKNA 39.83
  • BOTJ 43.75

About IKNA Ikena Oncology Inc.

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network. Its targeted oncology product candidate, IK-930, is an oral small-molecule inhibitor of the transcriptional enhanced associate domain, or TEAD, a transcription factor in the Hippo signaling pathway, a known oncogenic pathway that also drives resistance to multiple targeted and chemotherapies. Its other product candidates are IK-175 and IK-595.

About BOTJ Bank of the James Financial Group Inc.

Bank of the James Financial Group Inc is a bank holding company that provides retail and commercial banking, deposit services, lending services, mortgage brokerage services, and other banking services. The company provides a range of deposit services including checking accounts, savings accounts and other time deposits of various types, ranging from daily money market accounts to longer-term certificates of deposit. It offers various types of secured and unsecured consumer loans, including personal loans, lines of credit, overdraft lines of credit, automobile loans, installment loans, demand loans, and home equity loans. It operates three business segments, community banking; mortgage banking, and investment advisory services.

Share on Social Networks: